[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342951-105":59,"doc-detail-342951-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-novel-boron-dipyrromethene-erlotinib-conjugate-for-precise-photodynamic-therapy-against-liver-cancer","A Novel Boron Dipyrromethene-Erlotinib Conjugate for Precise Photodynamic Therapy against Liver Cancer","","Photodynamic Therapy (PDT) is a promising cancer treatment, yet conventional photosensitizers suffer from limited tumor selectivity and can damage healthy tissue when dosage and sunlight exposure are excessive. A new strategy integrates the small-molecule target erlotinib into a boron dipyrromethene (BODIPY)-based photosensitizer to form conjugate 6, improving PDT precision. Conjugate 6 preserves optical and singlet-oxygen properties while showing lysosome-accumulation, strong in vitro photocytotoxicity and selective preference for HepG2 cells. In vivo, it targets tumors and eradicates H22 tumors under laser illumination with good biosafety.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-novel-boron-dipyrromethene-erlotinib-conjugate-for-precise-photodynamic-therapy-against-liver-cancer/342951/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-novel-boron-dipyrromethene-erlotinib-conjugate-for-precise-photodynamic-therapy-against-liver-cancer/342951.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why can traditional photodynamic therapy damage healthy tissue?","Question",{"text":112,"@type":113},"Traditional PDT can cause harm when photosensitizer dosage and sunlight exposure lead to insufficient tumor selectivity, allowing reactive oxygen species to affect healthy tissues.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the purpose of integrating erlotinib into a BODIPY-based photosensitizer?",{"text":117,"@type":113},"The strategy creates a targeted conjugate (conjugate 6) to enhance precision in PDT while maintaining comparable optical absorption, fluorescence, and singlet oxygen generation efficiency to a reference compound lacking erlotinib.",{"name":119,"@type":110,"acceptedAnswer":120},"How does conjugate 6 affect cancer cells and tumor targeting?",{"text":121,"@type":113},"After internalization, conjugate 6 preferentially accumulates in lysosomes of HepG2 cells and shows strong photocytotoxicity (IC50 3.01 µM), with preferential uptake over HELF cells. In vivo, it exhibits affinity for tumor tissues and, combined with laser illumination, eradicates H22 tumors in mice with notable biosafety.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342951,1790533739,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":14,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Article  \nA Novel Boron Dipyrromethene-Erlotinib Conjugate for Precise Photodynamic Therapy against Liver Cancer  \nWenqiang Wu 1, Chengmiao Luo 2, Chunhui Zhu 2, Zhengyan Cai 1,* and Jianyong Liu 2,3, *  \n1 China State Institute of Pharmaceutical Industry, Pudong New Area, Shanghai 201203, China; [skysnine@163.com](skysnine@163.com)  \n2 Key Laboratory of Molecule Synthesis and Function Discovery, Fujian Province University, College of Chemistry, Fuzhou University, Fuzhou 350108, China; [l403186011@163.com](l403186011@163.com) (C.L.); [yuxun12181@163.com](yuxun12181@163.com) (C.Z.)  \n3 State Key Laboratory of Photocatalysis on Energy and Environment & National & Local Joint Biomedical Engineering Research Center on Photodynamic Technologies, College of Chemistry, Fuzhou University, Fuzhou 350108, China  \n* Correspondence: [caizy2007@163.com](caizy2007@163.com) (Z.C.); [lkw82@fzu.edu.cn](lkw82@fzu.edu.cn) (J.L.)  \nCitation: Wu, W.; Luo, C.; Zhu, C.; Cai, Z.; Liu, J. A Novel Boron Dipyrromethene-Erlotinib Conjugate for Precise Photodynamic Therapy against Liver Cancer. Int. J. Mol. Sci. 2024, 25, 6421. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25126421](10.3390/ijms25126421)  \nAcademic Editor: Young-Il Jeong  \nReceived: 7 May 2024  \nRevised: 27 May 2024  \nAccepted: 7 June 2024  \nPublished: 11 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nAbstract: Photodynamic Therapy (PDT) is recognized for its exceptional effectiveness as a promising cancer treatment method. However, it is noted that overexposure to the dosage and sunlight in traditional PDT can result in damage to healthy tissues, due to the low tumor selectivity of currently available photosensitizers (PSs) . To address this challenge, we introduce herein a new strategy where the small molecule-targeted agent, erlotinib, is integrated into a boron dipyrromethene (BODIPY)-based PS to form conjugate 6 to enhance the precision of PDT. This conjugate demonstrates optical absorption, fluorescence emission, and singlet oxygen generation efficiency comparable to the reference compound 7, which lacks erlotinib. In vitro studies reveal that, after internalization, conjugate 6 predominantly accumulates in the lysosomes of HepG2 cells, exhibiting significant photocytotoxicity with an IC50 value of 3.01 µM. A distinct preference for HepG2 cells over HELF cells is observed with conjugate 6 but not with compound 7. In vivo experiments further confirm that conjugate 6 has a specific affinity for tumor tissues, and the combination treatment of conjugate 6 with laser illumination can effectively eradicate H22 tumors in mice with outstanding biosafety. This study presents a novel and potential PS for achieving precise PDT against cancer.  \nKeywords: photosensitizer; photodynamic therapy; BODIPY; reactive oxygen species; erlotinib  \n1. Introduction  \nPhotodynamic therapy (PDT) is an innovative treatment option for an array of cancersand non-cancerous conditions [1–3] . It operates through the synergistic action of a photosensitizer (PS), light of a specific wavelength that matches the PS’s absorption spectrum, and molecular oxygen (3O2 ) . Upon exposure to light, the PS is excited to an excited singlet state (S1) from its ground state and then undergoes intersystem crossing (ISC) to arrive atan excited triplet state (T1). The PS in this state can transfer energy to 3O2 present in the surrounding tissues, resulting in the production of highly reactive singlet oxygen (1O2 ), a process known as the type II mechanism. Alternatively, the PS in T1 can also directly transfer an electron to 3O2 or other biological molecules, generating free radical specie","cbCaipN6RCIma1jA","https://ap.wps.com/l/cbCaipN6RCIma1jA","pdf",7665781,14,"English","# Introduction\n## Photodynamic therapy mechanism and advantages\n## Limitations of current photosensitizers\n## Strategies to improve tumor selectivity\n## Targeted conjugation approaches","[{\"question\":\"Why can traditional photodynamic therapy damage healthy tissue?\",\"answer\":\"Traditional PDT can cause harm when photosensitizer dosage and sunlight exposure lead to insufficient tumor selectivity, allowing reactive oxygen species to affect healthy tissues.\"},{\"question\":\"What is the purpose of integrating erlotinib into a BODIPY-based photosensitizer?\",\"answer\":\"The strategy creates a targeted conjugate (conjugate 6) to enhance precision in PDT while maintaining comparable optical absorption, fluorescence, and singlet oxygen generation efficiency to a reference compound lacking erlotinib.\"},{\"question\":\"How does conjugate 6 affect cancer cells and tumor targeting?\",\"answer\":\"After internalization, conjugate 6 preferentially accumulates in lysosomes of HepG2 cells and shows strong photocytotoxicity (IC50 3.01 µM), with preferential uptake over HELF cells. In vivo, it exhibits affinity for tumor tissues and, combined with laser illumination, eradicates H22 tumors in mice with notable biosafety.\"}]","A Novel Boron Dipyrromethene-Erlotinib Conjugate for Precise Photodynamic Therapy against Liver Cancer | PDF",1790049046,35,[147,151],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/11a7a34ccf52612f814000ac28c40a1d.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/c1c11a8a3fd996fbd8b20b0e5cff9398.webp",982,1388]